167 related articles for article (PubMed ID: 24570188)
41. Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage.
Felton D; Foley EM; Traub SJ; Vodonos A; Ganetsky M
J Emerg Med; 2016 Jan; 50(1):1-6. PubMed ID: 26409668
[TBL] [Abstract][Full Text] [Related]
42. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies.
Cartmill M; Dolan G; Byrne JL; Byrne PO
Br J Neurosurg; 2000 Oct; 14(5):458-61. PubMed ID: 11198768
[TBL] [Abstract][Full Text] [Related]
43. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients.
Beynon C; Jakobs M; Rizos T; Unterberg AW; Sakowitz OW
Br J Neurosurg; 2014 Jan; 28(1):29-33. PubMed ID: 24313307
[TBL] [Abstract][Full Text] [Related]
44. Pharmacist Presence Decreases Time to Prothrombin Complex Concentrate in Emergency Department Patients with Life-Threatening Bleeding and Urgent Procedures.
Masic D; Hidalgo DC; Kuhrau S; Chaney W; Rech MA
J Emerg Med; 2019 Nov; 57(5):620-628. PubMed ID: 31447188
[TBL] [Abstract][Full Text] [Related]
45. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
DeLoughery E; Avery B; DeLoughery TG
Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
[TBL] [Abstract][Full Text] [Related]
46. Prothrombin complex concentrate (Octaplex): a Portuguese experience in 1152 patients.
Carvalho MC; Rodrigues AG; Conceição LM; Galvão ML; Ribeiro LC
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):222-8. PubMed ID: 22450543
[TBL] [Abstract][Full Text] [Related]
47. Off-label use of 4-factor prothrombin complex concentrate is common despite little known benefit: A retrospective study.
Scharman CD; Shatzel JJ; Kim E; DeLoughery TG
Eur J Haematol; 2018 Sep; 101(3):349-353. PubMed ID: 29862565
[TBL] [Abstract][Full Text] [Related]
48. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
49. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
Brekelmans MPA; Ginkel KV; Daams JG; Hutten BA; Middeldorp S; Coppens M
J Thromb Thrombolysis; 2017 Jul; 44(1):118-129. PubMed ID: 28540468
[TBL] [Abstract][Full Text] [Related]
50. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
[TBL] [Abstract][Full Text] [Related]
51. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
[TBL] [Abstract][Full Text] [Related]
52. Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting.
Joseph R; Burner J; Yates S; Strickland A; Tharpe W; Sarode R
Transfusion; 2016 Apr; 56(4):799-807. PubMed ID: 26589481
[TBL] [Abstract][Full Text] [Related]
53. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
54. Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
Pabinger I; Tiede A; Kalina U; Knaub S; Germann R; Ostermann H;
Ann Hematol; 2010 Mar; 89(3):309-16. PubMed ID: 19787352
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
Hickey M; Gatien M; Taljaard M; Aujnarain A; Giulivi A; Perry JJ
Circulation; 2013 Jul; 128(4):360-4. PubMed ID: 23770745
[TBL] [Abstract][Full Text] [Related]
56. The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin.
Varga C; Al-Touri S; Papadoukakis S; Caplan S; Kahn S; Blostein M
Transfusion; 2013 Jul; 53(7):1451-8; quiz 1450. PubMed ID: 23067393
[TBL] [Abstract][Full Text] [Related]
57. Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates.
Hedges A; Coons JC; Saul M; Smith RE
J Thromb Thrombolysis; 2016 Jul; 42(1):6-10. PubMed ID: 26685667
[TBL] [Abstract][Full Text] [Related]
58. Experience on using prothrombin complex concentrate in urgent warfarin reversal: an Iranian survey.
Haghpanah S; Karimi M; Bordbar M; Kamfiroozi R; Asgharzadeh H
Clin Appl Thromb Hemost; 2013 Jun; 19(3):277-81. PubMed ID: 22734101
[TBL] [Abstract][Full Text] [Related]
59. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates.
Huttner HB; Schellinger PD; Hartmann M; Köhrmann M; Juettler E; Wikner J; Mueller S; Meyding-Lamade U; Strobl R; Mansmann U; Schwab S; Steiner T
Stroke; 2006 Jun; 37(6):1465-70. PubMed ID: 16675739
[TBL] [Abstract][Full Text] [Related]
60. Low-dose 3-factor prothrombin complex concentrate for warfarin reversal prior to heart transplant.
Kantorovich A; Fink JM; Militello MA; Wanek MR; Smedira NG; Soltesz EG; Moazami N
Ann Pharmacother; 2015 Aug; 49(8):876-82. PubMed ID: 25986007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
